日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies

肿瘤学领域卓越的转化研究:迈向新型、更有效的抗癌疗法之路

Rajan, A; Berns, A; Ringborg, U; Celis, J; Ponder, B; Caldas, C; Livingston, D; Bristow, R G; Hecht, T T; Tursz, T; van Luenen, H; Bono, P; Helander, T; Seamon, K; Smyth, J F; Louvard, D; Eggermont, A; van Harten, W H

Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial

多西他赛与多西他赛联合吉西他滨交替治疗晚期乳腺癌:一项随机试验的最终分析

Joensuu, H; Sailas, L; Alanko, T; Sunela, K; Huuhtanen, R; Utriainen, M; Kokko, R; Bono, P; Wigren, T; Pyrhönen, S; Turpeenniemi-Hujanen, T; Asola, R; Leinonen, M; Hahka-Kemppinen, M; Kellokumpu-Lehtinen, P

The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck

MDM2启动子多态性SNP309T→G与子宫平滑肌肉瘤、结直肠癌和头颈部鳞状细胞癌的风险相关

Alhopuro, P; Ylisaukko-Oja, S K; Koskinen, W J; Bono, P; Arola, J; Järvinen, H J; Mecklin, J-P; Atula, T; Kontio, R; Mäkitie, A A; Suominen, S; Leivo, I; Vahteristo, P; Aaltonen, L-M; Aaltonen, L A

Layilin, a novel integral membrane protein, is a hyaluronan receptor.

Layilin 是一种新型的整合膜蛋白,是透明质酸受体

Bono P, Rubin K, Higgins J M, Hynes R O

Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule

血管黏附蛋白1的克隆揭示了一种新型多功能黏附分子

Smith, D J; Salmi, M; Bono, P; Hellman, J; Leu, T; Jalkanen, S

CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73

CD73参与淋巴细胞与内皮细胞的结合:淋巴细胞-血管黏附蛋白2的特征分析表明它就是CD73。

Airas, L; Hellman, J; Salmi, M; Bono, P; Puurunen, T; Smith, D J; Jalkanen, S